Both in Biotechnology
IRulya Therapeutics vs REGENXBIO
Over the past year IRLA returned +22.8% and RGNX returned +3.3%; their daily moves had a correlation of 0.27.
IRLA +22.8% RGNX +3.3%Growth of $1, one year, split-adjusted
| Metric | IRLA | RGNX |
|---|---|---|
| Price | $39.78 | $8.03 |
| Market cap | $431.3M | $531.0M |
| Today | +3.78% | −5.19% |
| 1 month | +32.6% | +16.7% |
| 6 months | — | +28.6% |
| Year to date | — | −44.2% |
| 1 year | — | −30.5% |
| Revenue growth (YoY) | — | −69.2% |
| Gross margin | — | 87.5% |
| Net margin | — | −444.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.4× |
| Net cash | — | $251.0M |
| Dividend yield | — | — |
| Volatility (60d) | — | 89.0% |
| Short % of float | 14.2% | 19.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).